FSD Pharma Inc. HUGE
Set alert
0.09 +0.09 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 66.67K
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.75
- Beta
- 0.00
- Short ratio
- 0.11
- Inst. own
- 2.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 8.13
- 200-d avg
- 36.69
- 1y target
- 2.60
2Y chart
Events in this range
- May 12, 2023Earnings: —; estimate 0; surprise —%
- Jul 20, 2023Earnings: —; estimate 0; surprise —%
- Nov 14, 2023Earnings: —; estimate 0; surprise —%
- Mar 28, 2024Earnings: —; estimate 0; surprise —%
- May 14, 2024Earnings: —; estimate -0.05; surprise —%
- Aug 14, 2024Earnings: —; estimate -0.06; surprise —%
- Aug 15, 2024Split: 1 for 65
Signals (84)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 27, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 16, 2024 | 2 years ago |
| SMA: Bearish | Aug 12, 2024 | 2 years ago |
| SMA: Bullish | Aug 9, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 9, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 1, 2024 | 2 years ago |
| RSI: Oversold | Jul 30, 2024 | 2 years ago |
| RSI: Oversold | Jul 19, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 26, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 13, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 7, 2024 | 2 years ago |
| RSI: Oversold | May 31, 2024 | 2 years ago |
| RSI: Oversold | May 14, 2024 | 2 years ago |
| MACD: Buy Signal | May 10, 2024 | 2 years ago |
| RSI: Oversold | Apr 5, 2024 | 2 years ago |
| RSI: Oversold | Mar 25, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 29, 2024 | 2 years ago |
| SMA: Bullish | Feb 21, 2024 | 2 years ago |
| RSI: Overbought | Feb 21, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 31, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 18, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 9, 2024 | 2 years ago |
| MACD: Sell Signal | Nov 30, 2023 | 2 years ago |
| SMA: Bearish | Nov 29, 2023 | 2 years ago |
| SMA: Bearish | Nov 24, 2023 | 2 years ago |
| SMA: Bullish | Nov 21, 2023 | 2 years ago |
| RSI: Overbought | Nov 21, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 3, 2023 | 2 years ago |
| SMA: Bearish | Sep 22, 2023 | 3 years ago |
| SMA: Bearish | Sep 22, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 22, 2023 | 3 years ago |
| RSI: Overbought | Sep 15, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 12, 2023 | 3 years ago |
| SMA: Bullish | Aug 29, 2023 | 3 years ago |
| SMA: Bullish | Aug 29, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 25, 2023 | 3 years ago |
| SMA: Bullish | Aug 25, 2023 | 3 years ago |
| SMA: Bearish | Aug 23, 2023 | 3 years ago |
| SMA: Bearish | Aug 22, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 21, 2023 | 3 years ago |
| RSI: Overbought | Aug 9, 2023 | 3 years ago |
| SMA: Bullish | Aug 1, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jul 5, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 30, 2023 | 3 years ago |
| SMA: Bearish | Jun 29, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 29, 2023 | 3 years ago |
| SMA: Bearish | Jun 26, 2023 | 3 years ago |
| SMA: Bullish | Jun 20, 2023 | 3 years ago |
| MACD: Buy Signal | May 23, 2023 | 3 years ago |
| RSI: Oversold | May 9, 2023 | 3 years ago |
| SMA: Bearish | Apr 19, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 19, 2023 | 3 years ago |
| RSI: Overbought | Apr 10, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 6, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 4, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 28, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 28, 2023 | 3 years ago |
| RSI: Overbought | Feb 2, 2023 | 3 years ago |
| RSI: Overbought | Jan 31, 2023 | 3 years ago |
| RSI: Overbought | Jan 18, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 4, 2023 | 3 years ago |
| SMA: Bearish | Dec 6, 2022 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Nov 30, 2022 | 3 years ago |
| SMA: Bullish | Nov 29, 2022 | 3 years ago |
| SMA: Bearish | Nov 25, 2022 | 3 years ago |
| SMA: Bullish | Nov 23, 2022 | 3 years ago |
| SMA: Bearish | Nov 22, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 21, 2022 | 3 years ago |
| RSI: Overbought | Nov 11, 2022 | 3 years ago |
Key statistics
- Market cap
- 66.67K
- Enterprise value
- 287.16K
- Trailing P/E
- 0.00
- Forward P/E
- -0.75
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.01
- EPS (TTM)
- -16.25
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -10.05M
- Total cash
- 3.33M
- Total debt
- 625.20K
- Return on equity
- -63.89%
- Shares outstanding
- 708.61K
- Short % of float
- 0.44%
- 50-day average
- 8.13
- 200-day average
- 36.69
Analyst view
Consensus: buy
Buy
Price target (mean) 2.60
Next earnings
Aug 14, 2024
Expected Aug 14, 2024. Consensus EPS estimate -0.06.
Financials — quick view
HUGE Revenue — quarterly 0
HUGE Net income — quarterly -1.90M
HUGE EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 14, 2024 | Jun 1, 2024 | -0.06 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.05 | — | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Jul 20, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 12, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
About FSD Pharma Inc.
FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- Canada
- Website
- fsdpharma.com
News
- Court Sides with Quantum BioPharma in Dispute with Dr. Bokhari, Legal Battle Continues Over $2.8M Award
- Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
- Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
- Stocks That Hit 52-Week Lows On Friday
- Stocks That Hit 52-Week Lows On Wednesday
- 93 Biggest Movers From Friday
- Stocks That Hit 52-Week Lows On Monday
- 64 Biggest Movers From Friday
- A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
- 64 Biggest Movers From Friday
Your note
Sign in to keep a note on HUGE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Bokhari (Raza) | 10% Security Holder of Issuer | Redemption, retraction, cancelation, repurchase | Mar 28, 2022 | 5,527 |
| Carroll (Donal) | Director of Issuer | Acquisition or disposition in the public market | Sep 26, 2022 | 263,444 |
| Coyle (Nathan Patrick) | Senior Officer of Issuer | Acquisition or disposition in the public market | Jun 9, 2022 | 2,500 |
| Durkacz (Anthony John) | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Apr 24, 2022 | 273,597 |
| FSD Pharma, Inc. | Issuer | Redemption, retraction, cancelation, repurchase | Sep 25, 2022 | 219,400 |
| Kotra (Lakshmi) | Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | Acquisition or disposition in the public market | Dec 6, 2021 | 298,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Investments, LLC | 0.63% | 249,305 | 286.70K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.26% | 102,600 | 117.99K | Jun 29, 2023 |
| Susquehanna International Group, LLP | 0.15% | 57,465 | 66.08K | Jun 29, 2023 |
| Janney Montgomery Scott LLC | 0.04% | 15,000 | 17.25K | Jun 29, 2023 |
| Two Sigma Securities, LLC | 0.03% | 10,165 | 11.69K | Jun 29, 2023 |
| Royal Bank of Canada | 0.01% | 2,176 | 2.50K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 0.60% | 235,637 | 285.26K | Sep 29, 2023 |